LSM2 and glioblastoma: The diagnostic potential of LSM2 was assessed using receiver operating characteristic (ROC) curve analysis, which yielded an area under the curve (AUC) of 0.871 (95% CI: 0.838–0.904), confirming that LSM2 is a robust marker for distinguishing GBM from LGG (Figure 2F).